Blockage of TNF-α by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis

Journal of Investigative Medicine

Volumn 59, Issue 6, 2011, Pages 961-963

  Xia, Liping ^a   Lu, Jing ^a   Xiao, Weiguo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Chemokine; Chemokine receptor; Infliximab; Rheumatoid arthritis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; INFLIXIMAB; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; MALE; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

EID: 84863011018     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31821c0242     Document Type: Article

References (15)

1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356-361. (Pubitemid 40852711)
2. Haringman JJ, Ludikhuize J, Tak PP. Chemokines in joint disease: the key to inflammation? Ann Rheum Dis. 2004;63(10):1186-1194. (Pubitemid 39273491)
3. Hachicha M, Rathanaswami P, Schall TJ, et al. Production of monocyte chemotactic protein-1 in human type B synoviocytes. Synergistic effect of tumor necrosis factor alpha and interferon-gamma. Arthritis Rheum. 1993;36(1):26-34. (Pubitemid 23048675)
4. Min DJ, Cho ML, Lee SH, et al. Augmented production of chemokines by the interaction of type II collagen-reactive T cells with rheumatoid synovial fibroblasts. Arthritis Rheum. 2004;50(4):1146-1155.
5. Sedgwick JD, Riminton DS, Cyster JG, et al. Tumor necrosis factor: a master-regulator of leukocyte movement. Immunol Today. 2000;21(3):110-113. (Pubitemid 30122696)
6. Wiens A, Correr CJ, Venson R, et al. A meta-analysis of the efficacy and safety of using infliximab for the treatment of rheumatoid arthritis. Clin Rheumatol. 2009;28(12):1365-1373.
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-324. (Pubitemid 18091653)
8. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002;46(2):328-346.
9. Luther SA, Cyster JG. Chemokines as regulators of T cell differentiation. Nat Immunol. 2001;2(2):102-107. (Pubitemid 33707926)
10. Guglielmotti A, D'Onofrio E, Coletta I, et al. Amelioration of rat adjuvant arthritis by therapeutic treatment with bindarit, an inhibitor of MCP-1 and TNF-alpha production. Inflamm Res. 2002;51(5):252-258. (Pubitemid 34526441)
11. Shahrara S, Proudfoot AE, Park CC, et al. Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol. 2008;180(5):3447-3456.
12. Haringman JJ, Smeets TJ, Reinders-Blankert P, et al. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis. 2006;65(3):294-300. (Pubitemid 43268215)
13. Ellingsen T, Buus A, Stengaard-Pedersen K. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis. J Rheumatol. 2001;28(1):41-46. (Pubitemid 32062023)
14. Bruhl H, Cihak J, Schneider MA, et al. Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells. J Immunol. 2004;172(2):890-898. (Pubitemid 38113746)
15. Quinones MP, Ahuja SK, Jimenez F, et al. Experimental arthritis in CC chemokine receptor 2-null mice closely mimics severe human rheumatoid arthritis. J Clin Invest. 2004;113(6):856-866. (Pubitemid 38544144)